---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-22-029857"
form_type: "8-K"
ticker: "TLPH"
cik: "0001427925"
company_name: "TALPHERA, INC."
filed_at: "2022-12-29T23:59:59+00:00"
generated_at: "2026-06-20T21:51:50.248216+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# AcelRx raises ~$7.5M via registered direct offering of common stock and warrants

## Summary
- Sold 748,744 shares, pre-funded warrants for 2,632,898 shares, and common warrants for 4,227,052 shares at $2.22625 combined price.
- Gross proceeds ~$7.5M; Cantor Fitzgerald placement agent with 7% fee.
- Common warrants exercisable at $2.07 after 6 months, 6-year term, full ratchet anti-dilution with $1.00 floor.
- Amended prior warrant held by purchaser to reduce exercise price to $2.07.
- Closing expected on or about Dec 29, 2022.

## SEC filing metadata
- accession: 0001437749-22-029857
- form_type: 8-K
- ticker: TLPH
- cik: 0001427925
- company_name: TALPHERA, INC.
- filed_at: 2022-12-29T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1427925/000143774922029857/0001437749-22-029857-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1427925/000143774922029857/acrx20221227_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-22-029857
- JSON: https://secwatch.observer/filing/0001437749-22-029857.json
- Plain text: https://secwatch.observer/filing/0001437749-22-029857.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.